This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Indications

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Biopsy may assist in:

  • establishing a diagnosis
  • the planning of treatment and monitoring of its effect
  • assessing prognosis

Indications include:

  • persistent proteinuria or haematuria that is associated with renal impairment, for example, as assessed by GFR

  • nephrotic syndrome in patients less than 1 year or above 10 years of age - for children of intermediate age, the cause is most likely to be minimal change nephropathy; as this responds to steroid treatment, the risks of biopsy are thought to outweigh the likely benefits of treatment

  • acute renal failure that persists for more than 4 weeks without any active markers of intrinsic renal disease

  • chronic renal failure with normal sized kidneys

  • the investigation of systemic disorders that affect the kidneys, for example, amyloidosis or systemic lupus erythematosus

  • renal allograft dysfunction

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.